Increased hospital costs associated with red blood cell transfusion
- 8 December 2014
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 55 (5) , 1082-1089
Abstract
Background: Red blood cell (RBC) transfusion is independently associated in a dose‐dependent manner with increased intensive care unit stay, total hospital length of stay, and hospital‐acquired complications. Since little is known of the cost of these transfusion‐associated adverse outcomes our aim was to determine the total hospital cost associated with RBC transfusion and to assess any dose‐dependent relationship.Study Design and Methods: A retrospective cohort study of all multiday acute care inpatients discharged from a five hospital health service in Western Australia between July 2011 and June 2012 was conducted. Main outcome measures were incidence of RBC transfusion and mean inpatient hospital costs.Results: Of 89,996 multiday, acute care inpatient discharges, 4805 (5.3%) were transfused at least 1 unit of RBCs. After potential confounders were adjusted for, the mean inpatient cost was 1.83 times higher in the transfused group compared with the nontransfused group (95% confidence interval, 1.78‐1.89; p < 0.001). The estimated total hospital‐associated cost of RBC transfusion in this study was AUD $77 million (US $72 million), representing 7.8% of total hospital expenditure on acute care inpatients. There was a significant dose‐dependent association between the number of RBC units transfused and increased costs after adjusting for confounders.Conclusion: RBC transfusions were independently associated with significantly higher hospital costs. The financial implication to hospital budgets will assist in prioritizing areas to reduce the rate of RBC transfusions and in implementing patient blood management programs.Keywords
This publication has 31 references indexed in Scilit:
- The cost of blood transfusion in Western Europe as estimated from six studiesTransfusion, 2012
- Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantationHaematologica, 2011
- Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion OutcomesTransfusion Medicine Reviews, 2011
- Five Drivers Shifting the Paradigm from Product-Focused Transfusion Practice to Patient Blood ManagementThe Oncologist, 2011
- Frequency and Outcomes of Blood Products Transfusion Across Procedures and Clinical Conditions Warranting Inpatient Care: An Analysis of the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample DatabaseAmerican Journal of Medical Quality, 2010
- Blood transfusions: good or bad?Transfusion, 2010
- Activity‐based costs of blood transfusions in surgical patients at four hospitalsTransfusion, 2010
- Patient blood management – a new paradigm for transfusion medicine?ISBT Science Series, 2009
- Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgeryAmerican Heart Journal, 2006
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004